By using the TCL1-tg mouse model, which resembles the clinical CD49d high-risk group for CLL, PI3K, rather than BTK, was found as an essential part of the signaling between the BCR and VLA-4 [48], supporting the observation made in humans. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.